Exact Sciences Corporation
EXAS · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $10,350,029 | $13,327,053 | $8,731,138 | $13,336,015 |
| - Cash | $600,889 | $605,378 | $242,493 | $315,471 |
| + Debt | $2,754,758 | $2,554,725 | $2,446,871 | $2,382,108 |
| Enterprise Value | $12,503,898 | $15,276,400 | $10,935,516 | $15,402,652 |
| Revenue | $2,758,867 | $2,499,766 | $2,084,279 | $1,767,087 |
| % Growth | 10.4% | 19.9% | 17.9% | – |
| Gross Profit | $1,918,667 | $1,762,166 | $1,422,918 | $1,308,330 |
| % Margin | 69.5% | 70.5% | 68.3% | 74% |
| EBITDA | -$789,328 | $29,283 | -$421,105 | -$649,281 |
| % Margin | -28.6% | 1.2% | -20.2% | -36.7% |
| Net Income | -$1,028,857 | -$204,149 | -$623,506 | -$595,625 |
| % Margin | -37.3% | -8.2% | -29.9% | -33.7% |
| EPS Diluted | -5.59 | -1.13 | -3.54 | -3.48 |
| % Growth | -394.7% | 68.1% | -1.7% | – |
| Operating Cash Flow | $210,536 | $156,119 | -$223,559 | -$102,236 |
| Capital Expenditures | -$135,989 | -$124,190 | -$214,462 | -$135,766 |
| Free Cash Flow | $74,547 | $31,929 | -$438,021 | -$238,002 |